The Epidemiology of Multidrug Resistant Microorganisms in Antimicrobial Stewardship Era
A special issue of Antibiotics (ISSN 2079-6382). This special issue belongs to the section "Antibiotics Use and Antimicrobial Stewardship".
Deadline for manuscript submissions: closed (31 December 2022) | Viewed by 339
Special Issue Editor
Special Issue Information
Dear Colleagues,
Antimicrobial resistance (AMR) emerged as one of the leading public health problems at the end of 20th century and is currently a priority of public health. There were an estimated 1·27 million (0·911–1·71) attributable deaths associated with AMR in 2019 around the world. The World Health Organization (WHO), government agencies, and research groups have agreed that this is a global issue and coordinated action plans are needed to stop the spread of AMR. During the first decade of the new millennium, antimicrobial stewardship programs (ASP) appear to be a core element in antimicrobial optimization with a global vision covering issues such as animal use, primary care, and hospitalized care. More than a decade after dissemination and strong implementation of these programs, it is a good time to understand how on a global stage we can change the prevalence and resistance profiles of different pathogens after implementation of ASP.
This Special Issue calls for interventions or observational studies that address changes in the prevalence and resistance profile after ASP implementation. The theme includes studies at the health-system and policy levels; stewardship programs in hospitals, primary care facilities, and pharmacies; and interventions at the community level that cover both human and animal health.
We welcome original studies, reviews, and comparative analyses on the topic of ASP implementation
Dr. Emilio García-Cabrera
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- multidrug resistance
- antimicrobial stewardship
- antibiotic resistance mechanisms
- Public Health
- One Health
